Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XC8 for Dry Cough in Children with Acute Respiratory Infection
NCT06379542Phase 3Recruiting
- Sponsor
- Valenta Pharm
- Start
- Dec 2023
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of histamine glutarimide in dry cough, sponsored by Valenta Pharm. Started Dec 2023; status: recruiting.
02
Drugs
histamine glutarimide
03
Conditions
dry cough
Beyond the preview
Go deeper on NCT06379542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06379542.